The thyroid hormones (3,5,3',5 '-tetraiodo-L-thyronine [L-T4]' and 3,5,3'triiodo-L-thyronine [L-T3]) have marked effects on the growth, development, and metabolic function of virtually all organ systems and tissues of human beings and other higher organisms (1) (2) (3) . L-T4 was one of the first hormones to be isolated and its structure determined (4) (5) (6) . Several decades later L-T3 was identified in the circulation (7) (8) (9) . Although L-T3 is secreted by the thyroid gland, a significant amount is derived from peripheral conversion of L-T4 to L-T3 by 5'-deiodinases in various tissues (10) . L-T3 is about 10-fold more active than L-T4 on a molar basis (3) . Because of its higher intrinsic biologic activity, its conversion from L-T4 in various tissues, and its lower affinity for serum binding proteins, L-T3 plays a more dominant role than L-T4 in maintaining the normal euthyroid state (2). Because of the marked alterations in the rate of oxygen consumption identified in hypothyroidism and hyperthyroidism, initial studies on the mechanism of action ofthe thyroid hormones were focused on mitochondrial function. In vitro studies indicated that iodothyronines could alter the function of isolated mitochondria (1, 1 1) . However, this occurred only at iodothyronine concentrations 100,000-fold higher than those found in the euthyroid state, and L-T3 was less active than L-T4 (1 1).
In the 1960s Tata and co-workers showed that thyroid hormone administration increased the rate of RNA synthesis in rat liver suggesting that L-T3 and L-T4 might act by controlling gene expression (12, 13) . Research over the past decade using intact animals and cultured cells has provided compelling evidence that the thyroid hormones exert their effects in various cells and tissues by stimulating the accumulation of mRNAs which code for specific proteins. The following thyroid hormone-dependent effects have been studied in detail: stimulation of growth hormone synthesis in the rat anterior pituitary in vivo (14) ; regulation of growth hormone gene expression in cultured rat pituitary cell lines (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) ; stimulation of malic enzyme mRNA in the liver (25) (26) (27) (28) (29) , as well as several other genes that encode hepatic proteins of unknown function (SI and S14) (30) (31) (32) (33) ; and stimulation of the a-myosin heavy chain gene in the myocardium (34) (35) (36) (37) (38) . In addition to stimulating the expression of genes, the thyroid hormones also inhibit the expression of certain genes, most notably thyrotrophin (39) (40) (41) and the ,3-myosin heavy chain gene (34) (35) (36) (37) (38) . Of the genes indicated (both positive and negative regulation), the effect of the thyroid hormones has been shown to occur fully or to a significant degree at the transcriptional level.
Abundant evidence indicates that most if not all of the significant cellular responses regulated by the thyroid hormones in mammalian cells is mediated by a cellular receptor localized to the cell nucleus (2, 3). Evidence to support this notion has been derived from studies in intact animals (2, 33) and cultured cells (3, 23, 42, 43) . Several different related strains of growth hormone producing rat pituitary cell lines (GH,, GH3, GH4, and GC) have been shown to be highly effective cell culture models for studying thyroid hormone action. In these cells physiological concentrations of L-T3 and L-T4 stimulate growth hormone synthesis and growth hormone mRNA accumulation (I15-24), and the kinetics of stimulation is similar to that found in the anterior pituitary after thyroid hormone injection (14) . These cell lines contain thyroid hormone nuclear receptors which have affinity and hydrodynamic properties similar to receptors in various tissues in vivo. A review ofthe effect ofthe thyroid hormones on hepatic gene expression by thyroid hormone has recently been published by Oppenheimer et al. (33) . In this article we will provide an overview of recent developments in the field of thyroid hormone action that involve cloning of thyroid hormone receptor-related mRNAs and the use of the rat growth hormone gene as a model to identify cis-acting DNA sequences and trans-acting regulatory proteins required for transcriptional stimulation of the gene by thyroid hormone.
General properties ofthyroid hormone receptors
The properties of thyroid hormone nuclear receptors derived from studies using GH, and GC cells are listed in Table I . Similar results have been observed with receptor obtained from rat liver nuclei. The affinity of receptors for L-T3, L-T4, and other iodothyronines parallels the iodothyronine biologic potency in cultured cells (42) and in intact animals (44) . If the affinity for receptor and the biologic potency of L-T3 is assigned the value of 1, the values for several well-studied iodothyronines are: triiodothyroacetic acid (TRIAC) ( 
(> 0.01). These relative affinities have been found for receptor in rat brain, liver, and kidney, and for receptor in a variety of cultured cell lines derived from the rat and other species (3, 42, 44, 45) . Scatchard analysis of hormone binding to receptor demonstrates linear plots with no evidence for positive or negative cooperativity (46) (47) (48) (49) . GH, and GC cell nuclei contain -15,000-20,000 receptor molecules per cell nucleus (23, 46, 47, 49, 50) . The anterior pituitary and rat liver have -8,000-10,000 receptors per cell nucleus while other tissues have lower levels of receptor abundance (51) (52) (53) . Unlike steroid hormone receptors, no cytoplasmic counterpart of the nuclear receptor has been identified when cells are lysed (47, 54) , and these receptors can associate with nuclear components in the absence of ligand (47, 48, 55) . Thyroid hormone receptor in nuclear extracts can bind to DNA in vitro (56, 57) , and the receptor appears to be predominantly associated with linker DNA regions in chromatin (57) (58) (59) . The receptor, extracted from nuclei with buffer containing 0.4 M KCI, has a sedimentation coefficient of 3.8 S, a Stokes radius of 3.3 nm, and a particle density of 1.36 g/cm3, and micrococcal nuclease digestion studies of chromatin indicate that the receptor appears to protect a DNA fragment of about 35 base pairs (57) . Using the sedimentation coefficient (3.8 S), the Stokes radius (3.3 nm), and the particle density (1.36 g/cm3), the molecular weight (Me) of the salt extracted receptor was estimated to be 54,000 (57) . Similar results have also been reported for receptor extracted from rat liver nuclei by high salt (Mr = 50,000, Stokes radius = 3.5 nm) (60) . The DNA-binding properties of the receptor is retained when the salt concentration is lowered to 0.1 M KCI (56, 57) , and the affinity of salt extracted receptor for iodothyronines (47) is identical to receptor in isolated nuclear preparations (61) , suggesting that the interaction of receptor with DNA does not alter its affinity for ligand.
Photoaffinity labeling identifies several molecular weight forms ofreceptor in GH, cells
The structure of the receptor was examined in more detail using a photoaffinity label derivative of L-[125I]T3 (62) in which the amino group of the alanine side chain was derivatized to form a peptide bond with 2-diazo-3,3,3-trifluoropropionate to form N-2-diazo-3,3,3-trifluoropropionyl-L-T3 (L-T3-PAL). This compound has -'IAo of the affinity of L-T3 for receptor and can be covalently coupled to receptor in intact cells and in solubilized receptor preparations. On exposure to ultraviolet light (254 nm) the 2-diazo-3,3,3-trifluoropropionyl moiety generates a highly reactive carbene intermediate which covalently modifies residues which are sterically favored in the hormone binding domain. Fig. 1 (63) . Two domains of the avian erythroblastosis virus genome were functionally identified: the v-erb-A region and the v-erb-B region (63) . The v-erb-B gene has been shown to encode a truncated constitutively active epidermal growth factor receptor (64-68). Although it had been shown by deletion studies that v-erb-B is responsible for the transforming potential of the avian erythroblastosis virus this function required the expression of the v-erb-A gene for full oncogenic potential (69) (70) (71) . A human homologue of the v-erb-A gene was identified on human chromosome 17 near the break point found typically in human promyelocytic leukemia, while c-erb-B was localized to chromosome 7 (72) (73) (74) . Using v-erb-A sequences as a probe, Vennstrom and Bishop (75) first identified that chick cells expressed a cellular homologue (c-erb-A) of the v-erb-A gene.
After the cloning of the human glucocorticoid receptor cDNA (76), Weinberger et al. (77) pointed out that a cysteinerich region ofthe glucocorticoid receptor showed a high degree of amino acid homology (-50%) with a cysteine-rich region of the avian erythroblastosis virus v-erb-A gene. With the cloning of other steroid hormone gene receptor cDNAs (e.g., progesterone and estrogen receptor) (78) (79) (80) (81) , the cysteine-rich region of each receptor was also found to show high homology with the cysteine-rich region of the v-erb-A gene. Based on a comparison of the regions of amino acid homology of the human and chick estrogen receptor, Krust et al. (81) divided the domains of the proteins into regions defined as "A," "B," "C," "D," "E," and "F." Between the chick and human estrogen receptors the cysteine-rich C regions showed 100% homology and the long E region at the carboxy-terminal end of the protein showed 94% homology. Other regions showed much lower levels of homology. The C region of the various steroid receptors has been mapped to the DNA-binding region of the receptor (82, 83), and the sequence of the cysteine-rich region is similar but not identical to other regulatory proteins (e.g., TFIIIA) which contain zinc-associated "DNA-binding fingers." However, other regions of the molecule may also be important in influencing the transcriptional response which might mediate protein-protein contact of receptor with other regulatory proteins. The conserved E region of the various steroid receptors appears to contain the ligand-binding domain and shows very low homology between the different receptors (e.g., estrogen and glucocorticoid receptor) (81) .
Using v-erb-A probes corresponding to the E region of the viral gene, cellular homologues of v-erb-A have recently been isolated from a chick embryo cDNA library (75, 84) and a human placenta cDNA library (85) . The reticulocyte lysate in vitro translation products of these cDNAs were found to bind L-T3, L-T4, and other iodothyronine analogues with the same relative affinity (84, 85) as found for thyroid hormone nuclear receptor in GH, cells and other rat tissues (42, 45) . The chick c-erb-A encodes a 408-amino acid protein while the human c-erb-A isolated from the placental library encodes a 456-amino acid protein. The gene that encodes the human erb-Arelated mRNA was localized to chromosome 3 (85) whereas previous studies localized a v-erb-A-related sequence to chromosome 17 (72, 73) , suggesting that the human genome has at least two erb-A-related genes.
SDS-gel electrophoresis of the in vitro translation products of the cloned placental-derived human c-erb-A yields 55,000-and 52,000-Mr proteins which likely correspond to the 52,200-and 49,100-Mr proteins that would be initiated by different AUG codons in the same open reading frame as predicted by the nucleotide sequence (85) . Translation ofthe chick c-erb-A forms a protein which migrates with an Mr of 46,000 in SDS gels (the nucleotide sequence predicts a protein with an Mr of 46,700) (84). Unlike the cloned chick c-erb-A, the v-erb-A gene product (75,000 Mr containing viral gag sequences at the amino terminus) does not to bind thyroid hormone (84). However, it is a DNA-binding protein, suggesting that it might interact with functional sequences to block or constitutively activate gene expression (84) . Both the human and chick c-erb-A clones show high homology within the putative DNA binding C region (68 amino acids) and by analogy to steroid hormone receptor cDNAs, the putative ligand-binding E region (206 amino acids) (84, 85). However, other regions ofthe c-erb-A cDNAs are less conserved and it has been suggested that the cloned chick c-erb-A is more related to the erb-A gene on human chromosome 17 rather than chromosome 3 (85) .
Photoaffinity labeling was used to identify the receptor forms in human cells and the results are shown in Fig. 2 along with a parallel experiment using GH1 cells (86) . Several Mr forms ofthyroid hormone receptor in human fibroblasts (lanes I and 2) were identified which are not identical but are in the same molecular weight range as the receptor in GH, cells (lanes 3 and 4). The receptor species in fibroblasts are much less abundant than receptor in GH, cells and the photoaffinity-labeled human receptor species were estimated to have Mr values of 55,000, 52,000, and 45,000 with the 52,000-Mr form being the most abundant. Two of these species may correspond to the Mr forms generated by in vitro translation of the cloned human c-erb-A mRNA (55,000 and 52,000 Mr) which appear to reflect initiation at two distinct AUG codons in the same open reading frame (85) . The 45,000Mr photoaffinity- however, were not indicated. In contrast with the erb-A-related cDNA isolated from the human placental cDNA library, the rat brain erb-A-related cDNA showed preferential hybridization to human chromosome 17. The rat brain erb-A cDNA showed greater homology with the chick c-erb-A in the putative DNA binding C region (97%) and the putative ligandbinding E region (94%) than in the comparable regions of the human placental c-erb-A (90% in the C region and 85% in the E region). Hybridization studies with the rat brain c-erb-A using total RNA from a variety of tissues and cells identified an abundant 2.6-kb mRNA and less abundant mRNA species of about 5.0 and 6.0 kb in brain, kidney, gut, heart, and to a lesser degree in lung, testes, and spleen but not in liver, suggesting that this erb-A-related mRNA is expressed in a tissuespecific manner. However, hybridization to poly(A+) mRNA from liver was not reported, and the liver RNA was not hybridized to other erb-A probes documenting that erb-A-related mRNAs could be identified in the liver RNA preparation. In addition to the apparent low expression of an mRNA related to the brain erb-A cDNA in liver, the relative affinity of the translated erb-A protein for TRIAC, L-T3, and L-T4 was reported to be different from that of the endogenous receptor studied in liver and in GHI cells in that the affinities for TRIAC and L-T3 were identical and the affinity for L-T4 was -50-fold lower than the other two compounds (87) . These relative affinities, however, differ from that reported to occur in rat brain nuclei (45) , suggesting that the cloned rat-brain cDNA protein is not significantly expressed in brain or is expressed in a small subset of brain cells so that it would not be detected when analyzing whole-brain nuclei.
Benbrook and Pfahl (88) recently isolated a c-erb-A clone from an adult human testes library which encodes a protein of 490 amino acids and shows greater homology with the chick c-erb-A in the putative DNA-binding C region (96%) and the putative ligand-binding E region (94%) than in the comparable regions of the human placental c-erb-A (87% in the C region and 84% in the E region). The high homology with the chick c-erb-A protein suggests that this human c-erb-A may be a product of the previously identified v-erb-A-related gene on human chromosome 17. However, the affinity of only L-T3 was reported so it is not known whether the ligand-binding properties of this human c-erb-A is similar to or different from that reported for the other cloned erb-A-related cDNAs isolated from chick embryo, human placenta, and rat brain.
The identification of several erb-A thyroid hormone receptor-related cDNA clones have been interpreted to suggest tissue-specific or functional heterogeneity of thyroid hormone receptors (87) . In our view, however, the information available is too premature to draw these conclusions. First, as of yet no information is available indicating that these cloned erb-A proteins regulate gene expression in a functionally different fashion or influence the expression of different genes. Secondly, two of the cDNAs have been isolated from embryonic tissues and may not be expressed in the neonatal or adult organism. Lastly, all ofthe cloned erb-A cDNA contain multiple small open reading frames prior to the correct translation initiation site which markedly decreases the efficiency of translation of the erb-A proteins in vitro (84, 85, 87, 88) . The role ofthese small open reading frames is unclear but raises the possibility that posttranscriptional mechanisms may determine the efficiency of translation of a specific erb-A-related receptor mRNA. Therefore, the fact that a specific size erb-A mRNA is more abundant than other erb-A-related species does not necessarily indicate that it codes for the nuclear associated receptor detected in a particular cell or tissue. This will require the cDNA cloning of the different size erb-A-related mRNAs in various tissues followed by the development of specific antibody probes to assess the level of expression the protein encoded by each ofthe erb-A-related mRNAs. Nevertheless, cloning of these erb-A mRNAs represents a major advance in the field ofthyroid hormone action and should facilitate our understanding of how the receptor functions to transcriptionally regulate gene expression.
DNA sequences ofthe rat growth hormone gene that mediate basal and regulated expression by thyroid hormone Studies of a number of thyroid hormone-responsive genes indicate that regulation occurs fully or in part at the transcriptional level, and this is true for genes in which L-T3 stimulates (e.g., rat growth hormone) (21) (22) (23) or inhibits (e.g., thyrotrophin) (39) (40) (41) expression. The transcription rate of the growth hormone and thyrotrophin genes are modulated within minutes of thyroid hormone exposure (23, 40) . Furthermore, changes in the rate of transcription of these genes parallel the level of nuclear associated hormone-receptor complexes (23) . These results support the notion that the thyroid hormone-receptor complex binds to cis-acting DNA sequences (referred to as a thyroid hormone response element) which influences the transcription rate of the gene. Virtually all thyroid hormoneresponsive genes (e.g., rat growth hormone, thyrotrophin, S14, malic enzyme, and the a-myosin and #-myosin heavy chain genes) are regulated in a cell-or tissue-specific fashion. Therefore, in addition to defining the location of a thyroid hormone response element(s) it is also essential to identify the trans-acting factors and cis-acting elements involved in mediating cellspecific expression to fully understand how thyroid hormone modulates the expression of these genes.
Since the sequence of the rat growth hormone gene is known and cultured rat growth hormone-producing cells are available for transfection, current information regarding the cis-acting elements and trans-acting factors involved in thyroid hormone-regulated expression have come from studies of the rat growth hormone gene (89) (90) (91) (92) (93) (94) (95) (96) (97) (98) (99) . However, as discussed below, some disagreement exists concerning the location ofthe cis-acting sequences of the rat growth hormone gene that mediate cell-specific and thyroid hormone-regulated expression. The location and sequence of the regulatory elements identified in the various studies (89-99) is illustrated in Fig. 3 (95, 99) . In contrast, GC cells and GH4C1 cells showed basal CAT expression with the -145 and -104 deletion mutants (95, 99) . The three-to fourfold higher degree of basal expression of the -145 compared with the -104 deletion mutant indicated that sequences between -145 and -104, which are highly conserved among the rat, human, and bovine growth hormone genes, play an important role in enhancing the extent of basal expression of the gene (95). This conclusion is further supported by studies that indicate that a cell-specific nuclear protein, found only in rat growth hormone-producing cells, generates a DNase I footprint between -95 and -65 (96, 99, 101 ) and between -137 and -107 (99, 102) . The location of these cell-specific DNA elements (indicated as CSE) is shown in Fig. 3 . Similar results were reported for the human growth hormone gene (103) , and this protein was found to enhance transcription of the human gene in an in vitro HeLa cell transcription system (104).
The distance between the two footprinted regions, which center at -80 and -122, is exactly four helical turns of DNA. This indicates that the proteins that interact with these regions reside on the same side of the DNA helix favoring proteinprotein interactions. By altering the helical and spatial relationship between the -95/-65 and the -137/-107 regions, Ye et al. (99) have provided evidence that the enhanced level of cell-specific basal expression of the -145 vs. the -104 promoter involves an interaction of the proteins that bind to the two regions. Evidence has been presented that the protein-DNA complexes that form in the two regions may be generated by the same protein, or by proteins which recognize a similar sequence motif (TAAAT) found at the center of the two footprinted regions (99, 103) . Therefore, studies with both the rat and human growth hormone genes strongly support the notion that the -137/-107 and -95/-65 regions (Fig. 3) function as elements which mediate cell-specific basal expression of these genes. These and other studies by Nelson et al. (90) using other heterologous cells and a pGH-cat plasmid extending to -235, differ with recent studies by Larsen et al. (92) who reported that a "silencer" element, located between -554 and -237, is responsible for the suppression of rat growth hormone gene expression in heterologous but not homologous cells. The reason for this discrepancy is unclear and requires additional investigation.
Both cell-specific and thyroid hormone response elements are involved in thyroid hormone stimulation ofrat growth hormone gene expression Flug et al. (95) examined whether the highly conserved region between -145 and -104 was essential for thyroid hormoneregulated expression by studying L-T3 regulation of internal deletion mutants in which upstream sequences (e.g., -530/-237 and -236/-146) were ligated to the -104 promoter region. Only the -236/-146 region conferred L-T3 regulated expression to the -104 promoter, indicating that sequences upstream of -236 and between -146 and -104 are not essential for regulated expression by thyroid hormone. In a more recent study, Ye et al. (99) found that DNA from -236/-178 conferred full L-T3 regulation to the -104 rat growth hormone gene promoter and the sequence (-236/ -178) functioned in either normal or inverted orientations. No significant L-T3 stimulation resulted when a sequence from -181 to -146 was ligated in either orientation to the promoter, while full L-T3 stimulation occurred when only a 3 1-nucleotide fragment extending from -208 to -178 (Fig. 3 , sequence A) was ligated to the -104 gene promoter (99) . In contrast with the -104 homologous rat growth hormone promoter, sequences between -236 and -146 did not confer L-T3 regulation to an enhancerless SV40 viral promoter, indicating that the upstream region necessary for thyroid hormone-regulated expression functions most efficiently with its homologous promoter (95) . Similar results were also found using an enhancerless Rous sarcoma viral promoter (99) . However, regulated expression of these heterologous promoters occurred if sequences containing the cell-specific basal elements were ligated to the foreign promoter along with the upstream thyroid hormone response element, and this occurred independently ofthe orientation of these elements (99) . These results suggested that the thyroid hormone and cell-specific elements of the rat growth hormone gene function as an enhancerlike unit, and are both required to confer efficient thyroid hormone regulated expression to heterologous promoters. Ye et al. (99) proposed that thyroid hormone stimulates gene expression by acting via its receptor to enhance the function of the cell-specific basal element(s). This model proposed that the receptor binds to the -208/178 region (99) , and that the L-T3-receptor complex acts to "stabilize" or "enhance" the protein-DNA interactions of the cell-specific basal element to form a more "active" transcription complex which stimulates the level of gene expression.
Protein-DNA interactions ofsequences that function as thyroid hormone response elements To clarify the above or other models of thyroid hormone regulation of gene expression, it is important to document that the receptor binds to the sequences which function as a thyroid hormone response element. A direct interaction of receptor with these sequences would strengthen the notion that the L-T3 receptor complex directly activates the gene, and that stimulation is not mediated by another gene product stimulated by L-T3. In a recent study, Koenig et al. (97) ligated sequences from -210 to -126 and from -237 to -139 to the rat growth hormone promoter extending to -137. Both recombinants showed stimulation by L-T3. However, no stimulation was found when sequences between -190 and -172 were deleted from these fragments, suggesting that a thyroid hormone response element was fully or in part localized to this region (Fig. 3, sequence B) . Using a partially purified thyroid hormone receptor preparation from rat liver (0.2%) and a -237/-56 fragment ofthe hooded rat gene, methylation interference was used to attempt to footprint the receptor binding region (97 (99) indicate that DNA between -209 and -166 functions as a thyroid hormone response element which is involved in regulated expression ofthe rat growth hormone gene. The difference in the location of this element(s) identified by these transient expression studies (91, 95, (97) (98) (99) , and also the element reported by Wight et al. (94) (-254/-241) using stable transformation (Fig. 3) , raises the possibility that several regions may be able to function as a thyroid hormone response element, depending on the location of these sequences relative to other regulatory elements of the promoter element, and the nature of the promoter used for functional analysis. More definitive studies are required to fully document the precise location ofthe sequence that functions as the dominant thyroid hormone response element of the gene. This will require constructing a series of point or multiple mutations across the -254/-166 region of the gene using the 5'-flanking region containing sequences from -254 to +7. Analysis of the function of these recombinants coupled with footprinting studies of these constructions using purified receptor in vitro are required to precisely identify the DNA sequences required for thyroid hormone regulated expression of the rat growth hormone gene.
Precise identification of the region(s) required for thyroid hormone regulated expression of the rat growth hormone, however, will not provide a complete picture of how the thyroid hormone-receptor complex activates or inhibits gene expression. As indicated above, the results of Ye et al. (99) suggested that both an upstream thyroid hormone response element and a cell-specific basal element are necessary for L-T3 regulation of the rat growth hormone gene. To account for these observations a mechanism for L-T3 stimulation of ex-pression of the rat growth hormone gene was proposed in which receptor and cell specific protein-protein interactions occur. In this model it is assumed that the receptor binds to its cognate sequence and the L-T3 receptor complex acts to stabilize or enhance the protein-DNA interactions ofthe cell-specific basal element to form a more active transcription complex which increases the level of gene expression. This model can be tested by in vivo footprinting of the cell-specific elements of the endogenous rat growth hormone gene after L-T3 incubation. In vivo footprinting might also determine whether the thyroid hormone receptor binds to the same sequences in situ as determined by footprinting studies using purified receptor in vitro.
Recent studies on the mouse mammary tumor virus (MMTV) promoter support an analogous two-element model for glucocorticoid hormone stimulation of gene expression. Inactivation of the binding site for the NF-I transcription factor (or a protein with a similar recognition sequence; e.g., TGGCA-binding protein) markedly lowers stimulation by glucocorticoid hormones without significantly altering the basal activity of the gene (105, 106). Furthermore, in vivo footprinting indicates that glucocorticoid hormone incubation increases the association of NF-I with its cognate sequence (107) suggesting that the glucocorticoid receptor enhances NF-I binding or interacts with NF-I to form a transcription complex which activates expression of the MMTV promoter. Since the control elements of thyroid hormone-responsive genes other than rat growth hormone have not yet been reported, it is not possible to determine whether two elements are necessary for efficient L-T3-regulated expression in other systems. However, it provides a mechanism to explain how thyroid hormone, presumably acting via the same receptor, can positively (e.g., rat growth hormone) or negatively (e.g., thyrotrophin) regulate gene expression. Whether positive or negative regulation occurs would be dependent on the hormone-receptor complex acting in cis to enhance or suppress the effect of a second trans-acting regulatory protein(s) that plays a central role in determining the rate of expression ofthe gene.
Additional studies are required to support this hypothesis since positive and negative regulation may be mediated by structurally similar but different thyroid hormone receptors. The observation that the human genome contains at least two erb-A-related genes on different chromosomes raises this possibility (72) (73) (74) 85) . Significant progress has been made in the area of thyroid hormone action since the initial identification of thyroid hormone nuclear receptors in liver and kidney (52) and in cultured cells (46) . Future advances in this field will require the cloning ofthyroid hormone receptor mRNAs from various tissues and cells to identify their structure and function. In addition, other thyroid hormone response genes are being isolated and sequenced. Identification of the thyroid hormone response elements of other genes and the regulatory proteins that mediate their expression should ultimately provide a comprehensive view of the detailed mechanisms involved in positive and negative regulation of thyroid hormone-responsive genes in various cells and tissues. 
